Biopharmaceutical Company Announces Agreement To Sell Its Skincare Business: $1M Cash

NovaBay Pharmaceuticals Inc. (NYSE: NBY), a leading biopharmaceutical company, has announced a significant business move that could reshape its future operations and financial outlook. The company has entered into an agreement to sell its DERMAdoctor skincare business, including all product inventory, for approximately $1.0 million in cash. $NovaBay Pharmaceuticals(NBY.US)$